Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia

It is still uncertain whether intestinal metaplasia (IM) of the esophagogastric junction (EGJ) plays a role in the development of adenocarcinoma of the esophagogastric junction (AEGJ). The purpose of the present study was to clarify the relationship between AEGJ and IM in Japanese patients. Forty‐eight AEGJ, <3 cm and centered within 1 cm of the EGJ, were investigated. The frequency of IM around AEGJ and the correlation between IM and clinicopathological features were examined. IM was present in the surrounding mucosa in 22 of 48 cases (46%), and was seen more frequently in older patients (P = 0.008). Lymph node metastasis was observed only in cases in which the tumors were not associated with IM (P = 0.017). The gastric phenotype was seen almost exclusively in the group without IM, while the intestinal phenotype was predominant in the group with IM (P = 0.003). The present study found a lower incidence of associated IM than Western studies, and there were significant differences in clinicopathological features between AEGJ with and without IM. It is suggested that AEGJ may develop via two distinct pathways in Japanese patients: IM‐related and IM‐unrelated.

[1]  Y. Doki,et al.  Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma , 2004, Gastric Cancer.

[2]  T. Smyrk,et al.  Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia , 2002, American Journal of Gastroenterology.

[3]  M. Kusano,et al.  Gastric and Intestinal Phenotypic Marker Expression in Gastric Carcinomas and Its Prognostic Significance: Immunohistochemical Analysis of 136 Lesions , 2001, Oncology.

[4]  A. Ochiai,et al.  Histologic heterogeneity and mucin phenotypic expression in early gastric cancer , 2001, Pathology international.

[5]  S. Yoshida,et al.  Early carcinoma of the gastric cardia in Japan , 2000, Cancer.

[6]  M. Koike,et al.  Distinction of differentiated type early gastric carcinoma with gastric type mucin expression , 2000, Cancer.

[7]  P. Fockens,et al.  Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction , 2000, Cancer.

[8]  A. Ruol,et al.  Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia , 2000, Cancer.

[9]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[10]  L. Hansson,et al.  Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. , 1999, Journal of the National Cancer Institute.

[11]  J. Lagergren,et al.  Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.

[12]  I. Kunnamo,et al.  Specialized columnar epithelium of the esophagogastric junction: prevalence and associations , 1999, American Journal of Gastroenterology.

[13]  M. Ikegami,et al.  Mucin histochemical analysis of minute gastric differentiated adenocarcinoma , 1999, Pathology international.

[14]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[15]  P. Malfertheiner,et al.  Intestinal metaplasia at the gastro-oesophageal junction:Helicobacter pylori gastritis or gastro-oesophageal reflux disease? , 1998, Gut.

[16]  A. Bhattacharyya,et al.  Intestinal metaplasia of the gastric cardia. , 1997, The American journal of gastroenterology.

[17]  M. Johnston,et al.  The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. , 1996, The American journal of gastroenterology.

[18]  A. Cameron,et al.  Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. , 1995, Gastroenterology.

[19]  J. Fraumeni,et al.  The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. , 1995, JAMA.

[20]  J. Fraumeni,et al.  The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric Cardia , 1995 .

[21]  R. Goyal,et al.  Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.

[22]  J. Peters,et al.  Is Barrett's metaplasia the source of adenocarcinomas of the cardia? , 1994, Archives of surgery.

[23]  M. Inoue,et al.  Life‐style and subsite of gastric cancer—joint effect of smoking and drinking habits , 1994, International journal of cancer.

[24]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[25]  A. Cameron,et al.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium. , 1992, Gastroenterology.

[26]  D. Jewell,et al.  Changing pattern of gastric cancer in Oxfordshire. , 1992, Gut.

[27]  J. Cameron,et al.  Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. , 1985, American journal of surgery.

[28]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  H. Sugano,et al.  Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. , 1968, Gan.